BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1267543)

  • 1. Determination of endogenous concentrations of norepinephrine and dopamine and their rates of synthesis in a single mouse brain: biphasic effects of (+)-amphetamine.
    Riffee WH; Gerald MC
    Arch Int Pharmacodyn Ther; 1976 Jan; 219(1):70-8. PubMed ID: 1267543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catecholamines and operant response rates in albino rats.
    Will B; Maurissen J; Ropartz P
    Psychopharmacol Commun; 1976; 2(3):219-29. PubMed ID: 996277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of d-amphetamine sulfate given to pregnant mice on activity and on catecholamines in the brains of offspring.
    Middaugh LD; Blackwell LA; Santos CA; Zemp JW
    Dev Psychobiol; 1974 Sep; 7(5):429-38. PubMed ID: 4426470
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of chronic administration of C-amphetamine on regional changes in catecholamines in the rat brain.
    Lynch M; Kenny M; Leonard BE
    J Neurosci Res; 1977; 3(4):295-300. PubMed ID: 615278
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the effects of D-amphetamine and L-amphetamine in reversing depression of mouse locomotor activity caused by reserpine.
    Proctor CD; Kirby J; Wood MH; Wade LH; King PK
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):108-15. PubMed ID: 4451411
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced locomotor activity following amphetamine in mouse-killing rats.
    Salama AI; Goldberg ME
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):162-9. PubMed ID: 4795753
    [No Abstract]   [Full Text] [Related]  

  • 7. 14 C-catecholamine synthesis in mouse brain during morphine withdrawal.
    Rosenman SJ; Smith CB
    Nature; 1972 Nov; 240(5377):153-5. PubMed ID: 4564989
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of delta9-tetrahydrocannabinol on the synthesis of dopamine and norepinephrine in mouse brain synaptosomes.
    Bloom AS
    J Pharmacol Exp Ther; 1982 Apr; 221(1):97-103. PubMed ID: 6278139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of effects of chlordecone on synthesis rates, steady state levels and metabolites of catecholamines in rat brain.
    Aldous CN; Chetty CS; Mehendale HM; Desaiah D
    Neurotoxicology; 1984; 5(2):59-65. PubMed ID: 6209598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of catecholamine depleting drugs and d-amphetamine on self-stimulation of the substantia nigra and locus coeruleus.
    Cooper BR; Konkol RJ; Breese GR
    J Pharmacol Exp Ther; 1978 Mar; 204(3):592-605. PubMed ID: 24729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for norepinephrine, dopamine and 5-hydroxytryptamine in rat brain.
    Rastogi RB; Singhal RL
    J Pharmacol Exp Ther; 1976 Sep; 198(3):609-18. PubMed ID: 978462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cycloheximide and d-amphetamine on brain catecholamines in two mouse strains.
    Carr LA; Wehry SM
    Pharmacol Biochem Behav; 1980 Aug; 13(2):193-7. PubMed ID: 7413690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings: The effects of amphetamine, 2-aminoindane and 2-aminotetralin on the concentrations of whole brain noradrenaline, dopamine, 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the mouse.
    Crooks PA; Little HJ; Rees JM
    J Pharm Pharmacol; 1973 Dec; 25():Suppl:124P. PubMed ID: 4150521
    [No Abstract]   [Full Text] [Related]  

  • 15. Some effects of dl-4-(2-hydroxy-3-isopropylaminopropoxy) indole (LB46) on brain monoamines and their precursors.
    Leonard BE
    Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):79-93. PubMed ID: 5072194
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence that serotonin mediates some behavioral effects of amphetamine.
    Sloviter RS; Drust EG; Connor JD
    J Pharmacol Exp Ther; 1978 Aug; 206(2):348-52. PubMed ID: 308099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: Determination of noradrenaline, dopamine, serotonin, 5-hydroxyindoleacetic acid, tyrosine and tryptophane in the isolated perfused rat brain.
    Niemeyer DH; Krieglstein J
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R71. PubMed ID: 4276624
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of L-tyrosine on brain monoamines in rats given intravenous amphetamine.
    Smith DG; Geis LS; Lyness WH
    Subst Alcohol Actions Misuse; 1984-1985; 5(6):293-8. PubMed ID: 6085821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A reliable and sensitive method for the simultaneous determination of dopamine, noradrenaline, 5-hydroxytryptamine and 5-hydroxy-indolacetic acid in small brain samples.
    Orsingher OA; Marichich ES; Molina VA; Ramírez OA
    Acta Physiol Lat Am; 1980; 30(2):111-5. PubMed ID: 6180600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.